![]() | ''Building a Sailboat in a Storm'': The Evolution of COVAX in 2021 and its Impact on Supplies to Southeast Asia''s Six Lower-Income Economies In the first half of 2021, COVID-19 vaccine doses from the COVAX Facility were in short supply, and the plan to mass produce COVAX vaccines through the Serum Institute of India (SII) faltered as the pandemic surged in India in March 2021. Khairulanwar Zaini is Research Officer at the ISEAS - Yusof Ishak Institute, Singapore. |
![hidden image for function call](https://upload.wikimedia.org/wikipedia/commons/c/ca/1x1.png)